Catalyst Wire Dossier Catalyst Wire Dossier

Irinotecan Hydrochloride 40 mg/2 mL

irinotecan hydrochloride · Armas Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Irinotecan Hydrochloride 40 mg/2 mL, covering 2018-12-28 to 2022-10-28. Get the full timeline:

Most recent: FDA Approved: IRINOTECAN HYDROCHLORIDE 40 MG/2 ML — Supplemental Application (Armas Pharmaceuticals Inc.)

See pricing